Company Sanofi

Equities

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris 11:39:44 2024-02-23 am EST After market 02:35:29 pm
89.71 EUR +1.09% Intraday chart for Sanofi 89.9 +0.21%

Business Summary

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:

- pharmaceutical products (71.4%): prescription drugs in the areas of specialty medicine (54.7% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (45.3%; mainly for the treatment of diabetes and cardiovascular diseases);

- human vaccines (16.8%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas;

- consumer health products (11.8%).

At the end of 2022, the group had 59 production sites throughout the world.

Net sales are distributed geographically as follows: France (5.3%), Europe (18%), the United States (42.5%), China (7.3%), Japan (3.8%), Brazil (2.1%), Russia (1.5%) and other (19.5%).

Number of employees: 91,573

Sales per Business

EUR in Million2021Weight2022Weight Delta
Pharmaceuticals
71.4 %
26,970 71.4 % 30,688 71.4 % +13.79%
Vaccines
16.8 %
6,323 16.7 % 7,229 16.8 % +14.33%
Consumer Healthcare
11.8 %
4,468 11.8 % 5,080 11.8 % +13.70%

Sales per region

EUR in Million2021Weight2022Weight Delta
United States
42.5 %
14,385 38.1 % 18,275 42.5 % +27.04%
Rest of the World
19.5 %
7,850 20.8 % 8,386 19.5 % +6.83%
Europe
17.9 %
7,503 19.9 % 7,703 17.9 % +2.67%
China
7.3 %
2,720 7.2 % 3,123 7.3 % +14.82%
France
5.3 %
2,256 6.0 % 2,296 5.3 % +1.77%
Japan
3.8 %
1,657 4.4 % 1,613 3.8 % -2.66%
Brazil
2.2 %
815 2.2 % 927 2.2 % +13.74%
Russia
1.6 %
575 1.5 % 674 1.6 % +17.22%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 19-08-31
Director of Finance/CFO 58 18-09-30
Chief Tech/Sci/R&D Officer - 16-08-31
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 21-12-31
Chief Tech/Sci/R&D Officer 49 23-09-10
Chief Tech/Sci/R&D Officer - 18-12-31
Director/Board Member 73 09-12-15
Public Communications Contact - -
Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 73 09-12-15
Director/Board Member 70 14-04-30
Director/Board Member 62 20-04-27
Director/Board Member 64 20-05-21
Director/Board Member 52 20-04-27
Director/Board Member - 05-02-28
Director/Board Member 65 22-05-02
Director/Board Member 58 19-04-29
Director/Board Member 58 21-04-30
Director/Board Member 56 21-03-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,264,799,969 1,110,144,426 ( 87.77 %) 10,900,000 ( 0.8618 %) 87.77 %

Shareholders

NameEquities%Valuation
L'ORÉAL
9.348 %
118,227,307 9.348 % 11 990 M €
Amundi Asset Management SA (Investment Management)
2.412 %
30,503,914 2.412 % 3 093 M €
Dodge & Cox
1.780 %
22,512,304 1.780 % 2 283 M €
Crédit Mutuel Asset Management SA
1.124 %
14,213,736 1.124 % 1 441 M €
SANOFI
0.9642 %
12,195,470 0.9642 % 1 237 M €
Lyxor International Asset Management SAS
0.5764 %
7,289,777 0.5764 % 739 M €
Predica Prévoyance Dialogue du Crédit Agricole SA (Invt Port)
0.5390 %
6,817,764 0.5390 % 691 M €
Groupe des Assurances du Crédit Mutuel SA
0.5066 %
6,406,902 0.5066 % 650 M €
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.4712 %
5,959,327 0.4712 % 604 M €
OFI Invest Asset Management SA
0.4076 %
5,155,445 0.4076 % 523 M €
NameEquities%Valuation
Dodge & Cox
3.093 %
78,250,193 3.093 % 3 905 M €
Dodge & Cox
3.093 %
78,250,193 3.093 % 3 905 M €
Fidelity Management & Research Co. LLC
0.8056 %
20,379,166 0.8056 % 1 017 M €
Fisher Asset Management LLC
0.5664 %
14,326,620 0.5664 % 715 M €
Boston Partners Global Investors, Inc.
0.5152 %
13,032,746 0.5152 % 650 M €
Merrill Lynch International
0.4056 %
10,260,690 0.4056 % 512 M €
Eaton Vance Management
0.3111 %
7,868,480 0.3111 % 393 M €
Invesco Advisers, Inc.
0.2735 %
6,919,101 0.2735 % 345 M €
BNY Mellon Investment Adviser, Inc.
0.2452 %
6,203,752 0.2452 % 310 M €
BlackRock Investment Management LLC
0.2165 %
5,477,302 0.2165 % 273 M €

Holdings

NameEquities%Valuation
13,909,587 60.40% 1,451,504,628 $
12,195,470 0.96% 1,236,770,662 $
EUROAPI
29.77%
28,298,074 29.77% 190,887,771 $
4,697,737 7.39% 28,515,264 $
1,919,455 7.30% 3,205,490 $
3,860,600 0.66% 2,874,255 $

Company contact information

Sanofi

46, avenue de la Grande Armée

75017, Paris

+33 1 53 77 40 00

http://www.sanofi.com
address Sanofi(SAN)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Medical Specialties
Pharmaceuticals: Major
Aventis, Inc.
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Biotechnology

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
88.74 EUR
Average target price
107.4 EUR
Spread / Average Target
+20.99%
Consensus
1st Jan change Capi.
-0.06% 120 B $
+31.46% 693 B $
+21.62% 552 B $
+3.11% 386 B $
+18.65% 328 B $
+14.71% 312 B $
+7.97% 210 B $
-4.95% 209 B $
-3.58% 197 B $
-3.39% 156 B $
Other Pharmaceuticals
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer